Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated April 07, 2025, titled "Sun Pharma introduces a novel class of drug, Fexuclue?(Fexuprazan) in India for treatment of Erosive Esophagitis ".
Press Release Apr 07 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Press Release Feb 17 2025
- Press Release Feb 04 2025
- Sun Pharma Presents LEQSELVI Data Highlighting Clinical Efficacy and Durability for Treatment of Alopecia Areata at the 2024 Fall Clinical Dermatology Conference
- Press Release Oct 25 2024
- Press Release Oct 15 2024
Later from Sun Pharmaceutical Industries
- Sun Pharmaceutical Industries Limited Press Release Apr 24 2025
- Sun Pharma and Moebius Medical Announce Dual Publications on MM-II's Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage
- Press Release May 08 2025
- Press Release May 12 2025
- Press Release May 16 2025
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries